Early detection with MRI of incomplete treatment of spine metastases after percutaneous cryoablation.
Adult
Aged
Cervical Vertebrae
Cone-Beam Computed Tomography
Cryosurgery
/ methods
Early Detection of Cancer
/ methods
Female
Fluoroscopy
Humans
Lumbar Vertebrae
Magnetic Resonance Imaging
/ methods
Male
Middle Aged
Neoplasm Metastasis
Positron Emission Tomography Computed Tomography
Retrospective Studies
Spinal Neoplasms
/ diagnosis
Surgery, Computer-Assisted
/ methods
Thoracic Vertebrae
Treatment Outcome
Young Adult
Cryotherapy
Magnetic resonance imaging
Neoplasm metastasis
Spine
Journal
European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
received:
09
10
2018
accepted:
24
01
2019
revised:
27
12
2018
pubmed:
17
3
2019
medline:
18
12
2019
entrez:
17
3
2019
Statut:
ppublish
Résumé
To evaluate post-ablation MRI for the detection of incompletely treated spinal osseous metastases (SOM) after cryoablation and to propose a post-ablation imaging classification. After IRB consent, all patients treated with cryoablation of SOM between 2011 and 2017 having at least 1-year minimum follow-up and a spine MRI within 4 months after cryoablation were retrospectively included. A classification of MRI images into four types was set up. The primary endpoint of our study was to assess the diagnostic performance of the post-ablation MRI. The secondary endpoints were the 1-year complete treatment rate (CTR) and complications. Fifty-four SOMs in 39 patients were evaluated. Post-ablation MRI was performed with a median delay of 25 days after cryoablation. Images were evaluated by two independent readers according to the pre-established image classification. Sensitivity and specificity for the detection of residual tumor were 77.3% (95%CI = 62.2-88.5) and 85.9% (95%CI = 75.0-93.4), respectively. Types I, II, III, and IV of the classification were associated with a 1-year complete treatment in 100%, 83.3%, 35.7%, and 10% of cases, respectively. The 1-year CTR was 59.3% for all 54 metastases, and 95.8% for metastases measuring less than 25 mm and at least 2 mm or more away from the spinal canal. Two grade 3 and two grade 2 adverse events according to the CTCAE were reported. MRI after cryoablation is useful for the evaluation of the ablation efficacy. The classification of post-cryoablation MRI provides reliable clues for the prediction of complete treatment at 1 year. • MRI performed 25 days after cryoablation is useful to evaluate the efficacy. • The proposed classification provides a reliable clue for complete cryoablation. • Percutaneous cryoablation of spinal metastases is highly effective for lesions less than 25 mm in diameter and of at least 2 mm away from the spinal canal.
Identifiants
pubmed: 30877460
doi: 10.1007/s00330-019-06040-y
pii: 10.1007/s00330-019-06040-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5655-5663Références
J Neurosurg Spine. 2012 Apr;16(4):379-86
pubmed: 22225488
Cancer. 1975 Aug;36(2):590-4
pubmed: 1157021
AJNR Am J Neuroradiol. 2016 Jan;37(1):189-95
pubmed: 26427837
Diagn Interv Imaging. 2014 Jul-Aug;95(7-8):659-63
pubmed: 25017149
Endocrine. 2018 Mar;59(3):547-554
pubmed: 29305799
Ann Oncol. 2015 May;26(5):987-991
pubmed: 25688058
Eur Radiol. 2013 Jul;23(7):1986-97
pubmed: 23455764
Lancet Oncol. 2012 Apr;13(4):395-402
pubmed: 22285199
Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6243s-6249s
pubmed: 17062708
Lancet Oncol. 2015 Dec;16(16):e595-603
pubmed: 26678212
Radiology. 2011 Jan;258(1):270-6
pubmed: 21045185
Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):484-90
pubmed: 18234445
Eur Radiol. 1998;8(8):1345-51
pubmed: 9853211
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Eur Radiol. 2014 Aug;24(8):1971-80
pubmed: 24859596
Eur Radiol. 2018 Oct;28(10):4146-4150
pubmed: 29651762
Eur J Radiol. 2009 Mar;69(3):567-73
pubmed: 18191356
AJR Am J Roentgenol. 2000 Dec;175(6):1619-25
pubmed: 11090390
Psychol Bull. 1968 Oct;70(4):213-20
pubmed: 19673146
J Clin Oncol. 2009 Oct 20;27(30):5075-9
pubmed: 19738130
Eur Radiol. 2011 Dec;21(12):2604-17
pubmed: 21887484
Semin Musculoskelet Radiol. 2011 Apr;15(2):125-34
pubmed: 21500132
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Ann Oncol. 2011 Feb;22(2):307-14
pubmed: 20624786
J Neurosurg Spine. 2017 Oct;27(4):428-435
pubmed: 28708043
J Nucl Med. 2010 Aug;51(8):1213-8
pubmed: 20660382